Leveraging Artificial Intelligence and Big Data to Optimize COVID-19 Clinical Public Health and Vaccination Roll-Out Strategies in Africa
暂无分享,去创建一个
Jianhong Wu | N. Bragazzi | A. Asgary | B. Mellado | J. Kong | K. Hayasi | B. Lieberman | X. Ruan | F. Stevenson | M. Kawonga | J. Orbinski | Thuso Mathaha | Nalamotse Choma | Mduduzi Mbada
[1] S. Madhi,et al. Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa , 2021, medRxiv.
[2] Jon Cohen. South Africa suspends use of AstraZeneca’s COVID-19 vaccine after it fails to clearly stop virus variant , 2021 .
[3] A. Afolabi,et al. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context , 2021, The Pan African medical journal.
[4] T. Haile,et al. The burden and outcomes of COVID-19 among patients with co-morbid disease in Africa: protocol for a systematic review and meta-analysis , 2020, New Microbes and New Infections.
[5] M. Cojocaru,et al. Simulating preventative testing of SARS-CoV-2 in schools: policy implications , 2020, BMC Public Health.
[6] J. Nachega,et al. From Easing Lockdowns to Scaling Up Community-based Coronavirus Disease 2019 Screening, Testing, and Contact Tracing in Africa—Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] Svetozar Zarko Valtchev,et al. Artificial Intelligence Model of Drive-Through Vaccination Simulation , 2020, International journal of environmental research and public health.
[8] N. Bragazzi,et al. The impact of non-pharmaceutical interventions, demographic, social, and climatic factors on the initial growth rate of COVID-19: A cross-country study , 2020, Science of The Total Environment.
[9] A. Afolabi,et al. COVID-19 pandemic response fatigue in Africa: causes, consequences, and counter-measures , 2020, The Pan African Medical Journal.
[10] Jianhong Wu,et al. A Drive-through Simulation Tool for Mass Vaccination during COVID-19 Pandemic , 2020, Healthcare.
[11] V. Galasso,et al. Gender differences in COVID-19 attitudes and behavior: Panel evidence from eight countries , 2020, Proceedings of the National Academy of Sciences.
[12] D. Fidler. Vaccine nationalism's politics , 2020, Science.
[13] J. Nachega,et al. From Easing Lockdowns to Scaling-Up Community-Based COVID-19 Screening, Testing, and Contact Tracing in Africa - Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] Sandro Colombo,et al. COVID-19 in Africa: the little we know and the lot we ignore. , 2020, Epidemiologia e prevenzione.
[15] C. Wiysonge,et al. Vaccine hesitancy – a potential threat to the achievements of vaccination programmes in Africa , 2018, Human vaccines & immunotherapeutics.
[16] M. Behzadifar,et al. Vaccines Meet Big Data: State-of-the-Art and Future Prospects. From the Classical 3Is (“Isolate–Inactivate–Inject”) Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview , 2018, Front. Public Health.
[17] R. Godfrey,et al. Urbanisation and health. , 2005, Clinical medicine.